Rasagiline improves freezing in a patient with primary progressive freezing gait

Movement Disorders

Volumn 23, Issue 3, 2008, Pages 449-451

  Coria Balanzat, Francisco ^a   Cozar Santiago, María del Puig ^b  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b Nuclear Medicine Institute   (Spain)

Author keywords

Brain perfusion SPECT; Freezing point of gait; MAOB inhibitors; Primary progressive freezing gait; Rasagiline

Indexed keywords

DOPAMINE TRANSPORTER; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; SELEGILINE; INDAN DERIVATIVE; MONOAMINE OXIDASE INHIBITOR;

AGED; ARTICLE; BRAIN CORTEX; BRAIN PERFUSION; CASE REPORT; DISABILITY SEVERITY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; FREEZING GAIT; FRONTAL LOBE; FUNCTIONAL ASSESSMENT; GAIT DISORDER; HUMAN; MALE; PARIETAL LOBE; PRIORITY JOURNAL; RATING SCALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; THALAMUS; TREATMENT DURATION; TREATMENT RESPONSE; BRAIN; DRUG EFFECT; METHODOLOGY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; SCINTISCANNING;

AGED, 80 AND OVER; BRAIN; DISEASE PROGRESSION; GAIT DISORDERS, NEUROLOGIC; HUMANS; INDANS; MALE; MONOAMINE OXIDASE INHIBITORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 43049158214     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21868     Document Type: Article

References (26)

1. Giladi N. Freezing of gait. Clinical overview. Adv Neurol 2001; 87:191-197.
2. Achiron A, Ziv I, Goren M, et al. Primary progressive freezing gait. Mov Disord 1993;8:293-297.
3. Atchison PR, Thompson PD, Frackowiak RS, Marsden CD. The syndrome of gait ignition failure: a report of six cases. Mov Disord 1993;8:285-292.
4. Nicaretta DH, Pereira JS, Pimentel ML. Primary progressive freezing gait. Case report. Arq Neuropsiquiatr 1997;55:496-498.
5. Factor SA, Jennings DL, Molho ES, Marck KL. The natural history of the syndrome of primary progressive freezing gait. Arch Neurol 2002;59:1778-1783.
6. Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology 2006;66:411-414.
7. Youdim MBH, Edmonson D, Tripton KF. The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 2006;7: 295-309.
8. Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with parkinsonism. Parkinsonism Relat Disord 2000;6:165-170.
9. Nutt JG, Marsden CD, Thompson PD. Human walking and higher level gait disorders, particularly in the elderly. Neurology 1993; 43:268-279.
10. Scherfler C, Schwarz J, Antonini A, et al. Role of DAT-SPECT in the diagnostic work up of Parkinsonism. Mov Disord 2007;22: 1229-1238.
11. Hashimoto T. Speculation on the responsible sites and pathophysiology of freezing of gait. Parkinsonism Relat Disord 2006;Suppl 2:S55-S62.
12. Fabre N, Brefel C, Sabatini U, et al. Normal frontal perfusion in patients with frozen gait. Mov Disord 1998;13:677-683.
13. Yener GG, Kaya GC, Ozturk V, Akdal G. Improvement in Tc-99m HMPAO brain SPECT findings during donepezil therapy in a patient with pure akinesia. Ann Nucl Med 2005;19:607-609.
14. Matsui H, Udaka F, Miyoshi T, et al. Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease. Mov Disord 2005;20:1272-1277.
15. Bartels AL, de Jong BM, Giladi N, et al. Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov Disord 2006;21:1326-1332.
16. Devos D, Krystkowiak P, Clement F, et al. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:470-475.
17. Zuniga C, Lester J, Cersosimo MG, Diaz S, Micheli FE. Treatment of primary progressive freezing of gait with high doses of selegiline. Clin Neuropharmacol 2006;29:20-21.
18. Gurevich T, Peretz C, Moore O, Weizmann N, Giladi N. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study. Mov Disord 2007;22:880-883.
19. Davis JT, Lyons KE, Pahwa R. Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson's disease. Clin Neurol Neurosurg 2006;108:461-484.
20. Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD. Prospective assessment in the DATATOP cohort. Neurology 2001; 56:1712-1721.
21. Parkinson Study Group. A randomized, placebo-controlled trial of rasagiline in levodupa-treated patients with Parkinson's disease and motor fluctuations. The PRESTO study. Arch Neurol 2005; 62:241-248.
22. Rascol O, Brooks DJ, Melamed E, et al. Rasagiline as an adjunct to levodopa in patients with PD and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily study): a randomized, double-blind, parallel-group trial. Lancet 2005;365:947-954.
23. Giladi N, Rascol O, Brooks DJ, et al. Rasagiline treatment can improve freezing of gait in advanced Parkinson's disease: a prospective, randomized, double-blind and entacapone controlled study. Neurology 2004;62 (Suppl. 5):A329-A330.
24. Rascol O. Rasagiline in the pharmacotherapy of Parkinson's disease. A review. Expert Opin Pharmacother 2005;6:2061-2075.
25. Kondo T. Drug intervention for freezing of gait resistant to dopaminergic therapy: a pilot study. Parkinsonism Relat Disord 2006; Suppl 2:S63-S66.
26. Giladi N, Hausdorff JM. The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease. J Neurol Sci 2006;248:173-176.